Biologics

Ossium Health's OssiGraft viable bone matrix allograft was used in its first patient case, according to a Dec. 14 news release.

Legislation has been introduced in the U.S. House that would require all bone graft material to be tested for active and latent tuberculosis. It would also expedite the process for developing a screening test, according to a Dec. 13 report…

Medical device company Alafair Biosciences has surpassed 12,000 implantations of its flagship product VersaWrap, the only class II medical device intended for use on tendon, ligament, skeletal muscle and peripheral nerve, including on nerve root in spine procedures. 

Orthopedic devicemaker Paragon 28 launched the Beast cortical fibers, the company said Nov. 14.

Here are three key updates on spine and orthopedic biologics since Oct. 10.

David Karli, MD, has opened an orthopedic regenerative medicine center focusing on bone marrow concentrate and micronized fat stem cell therapies in Miami, Fla.

Regenerative orthopedic developer Advanced Biologics has merged with orthobiologic firm Isto Biologics, according to an Oct. 24 report from the North Coast Current.

DiscGenics is partnering with the U.S. Department of Veterans Affairs to conduct research into forming tissue-engineered discs, according to an Oct. 18 news release.

Orthofix earned FDA 510(k) clearance for its OsteoCove advance bioactive synthetic graft, the company said Oct. 12.

Here are 11 key updates on orthobiologics from the third quarter of 2023: